Clinical studies recruiting near Kolkata

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3560002 · Sanofi · NCT06867094 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Nil Ratan Sircar Medical College and Hospital · Bristol-Myers Squibb · NCT06929273 Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · NRS Medical College and Hospital Kolkata · Walden Biosciences · NCT06466135 An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06666491 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Institute of Post Graduate Medical Education and Research an · Pfizer · NCT05895786 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Apollo Multispeciality Hospitals limited · Pfizer · NCT07144280 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Local Institution - 0286 · Bristol-Myers Squibb · NCT06976216 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Nil Ratan Sircar Medical College & Hospital · Boehringer Ingelheim · NCT06531824 Effects of Advanced Trauma Life Support® on Adult Trauma Patient Outcomes
NA · Institute of Post-Graduate Medical Education and Research an · Karolinska Institutet · NCT06321419 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Nil Ratan Sircar Medical College and Hospital · Biogen · NCT06962800 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · NRS Medical College and Hospital · Takeda · NCT06499285 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Add
Phase 4 · Netaji Subhas Chandra Bose Cancer Hospital · Bayer · NCT05348876 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Phase 4 · IPGMER & SSKM Hospital · Pharmazz, Inc. · NCT05956418 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · M. P. Birla Group - Belle Vue Clinic · Eli Lilly and Company · NCT07223593 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Apollo Multispeciality Hospital, Kolkata · Novo Nordisk A/S · NCT07571005 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 7404 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · Fortis Hospital · The George Institute · NCT06058585 Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Phase 2 · Institute of Child Health · Pfizer · NCT05639647 Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566 A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Local Institution - 0118 · Bristol-Myers Squibb · NCT07140913 A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Phase 4 · ILS Hospitals · Eli Lilly and Company · NCT07438444 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Tata Medical Center · Hoffmann-La Roche · NCT05894239 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 2314 · Anthos Therapeutics, Inc. · NCT05712200

Look up another city

Look up another condition